Advertisement
Product › Details
SURE CHO-MPlus™ Libraries
Next higher product group | CHO cell line | |
Status | 2013-04-17 sales start | |
Organisation | Selexis S.A. | |
Today | KBI BioPharma Inc. | |
Group | JSR Corporation (Group) | |
Record changed: 2017-04-01 |
Advertisement
More documents for CHO cell line
- [1] Atlas Antibodies AB. (7/28/21). "Press Release: Atlas Antibodies AB Acquires Evitria, a World Leader in Recombinant Antibody Expression". Stockholm & Zürich....
- [2] Selexis S.A.. (6/20/19). "Press Release: Avacta and Selexis Partner to Develop Cell Line for Clinical Manufacturing". Cambridge & Geneva....
- [3] Polyplus-transfection S.A.. (7/6/18). "Press Release: Polyplus-transfection Launches New Advanced System for Transient Protein Expression in CHO cells". Strasbourg....
- [4] Horizon Discovery Group plc. (8/1/17). "Press Release: Horizon Discovery Announces Release of High Quality, Well Annotated CHO Genome Sequence to Drive Innovation in Bioproduction". Cambridge....
- [5] Merck KGaA. (5/16/17). "Press Release: Merck’s CHOZN Expression System Selected for Bi-specific Antibody Development by SystImmune". Darmstadt....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top